Synendos Therapeutics AG Granted EMA Clinical Trial Authorisation for SYT-510
18 Jan 2024 //
PR NEWSWIRE
Professor Jürg Gertsch, Presents New Findings on an Endocannabinoid Transporter
18 Jul 2023 //
PR NEWSWIRE
Synendos Therapeutics Expands Series A to CHF 24 million with new investment
20 Apr 2021 //
PRESS RELEASE
Synendos Therapeutics Expands Series A to CHF 24 million with new investment
19 Apr 2021 //
PRNEWSWIRE